Read + Share
. Friedberg JW, Bordoni R, Patel-Donnelly D, et al. Brentuximab vedotin with
dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible
for chemotherapy. Blood. 2024;143(9):786-795. Blood 2024;144:1647.
PMID: 39388158
|
 |
|
